Trial intelligence / Profile preview

Yanhuang Xiaoxintong Capsule in Coronary Artery Disease Angina (Phase III)

CTR20150636Phase 3Active

Sponsor
Hunan University of Chinese Medicine
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Yanhuang Xiaoxintong Capsule in coronary arteriosclerosis, angina pectoris, sponsored by Hunan University of Chinese Medicine. Started Sep 2015; status: active.

02

Drugs

Yanhuang Xiaoxintong Capsule
03

Conditions

coronary arteriosclerosisangina pectoris

Beyond the preview

Go deeper on CTR20150636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call